CSIMarket
 


United Cannabis Corp  (CNAB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

United Cannabis's Leverage Ratio

CNAB's quarterly Leverage Ratio and Total Liabilities, Equity growth




CNAB Leverage Ratio (Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
Y / Y Equity Change -17.5 % -7.44 % 24.43 % 65.84 % 3129.27 %
Y / Y Total Liabilities Change 210.93 % 663.88 % 361.55 % 153.54 % 227.02 %
Leverage Ratio MRQ 1.85 1.1 0.73 0.31 0.49
Overall Ranking # # # # #
Seq. Equity Change -8.35 % -22.81 % -14.63 % 36.61 % 2.82 %
Seq. Total Liabilities Change 53.57 % 16.94 % 101.94 % -14.27 % 277.29 %



Leverage Ratio second quarter 2019 Comment
Due to net new borrowings of 53.57%, Leverage Ratio detoriated to 1.85, above company's average Leverage Ratio.

Within Biotechnology & Drugs industry in the second quarter 2019, 126 other companies have achieved lower Leverage Ratio than United Cannabis. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are CNAB Customers?
Leverage Ratio second quarter 2019 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 127
Healthcare Sector # 500
Overall Market # 2186


Leverage Ratio Statistics
High Average Low
5.62 1.69 0.01
(Dec 31 2013)   (Mar 31 2014)




Financial Statements
United Cannabis's Equity $ 5 Millions Visit CNAB's Balance sheet
United Cannabis's Total Liabilities $ 10 Millions Visit CNAB's Balance sheet
Source of CNAB's Sales Visit CNAB's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingJun 30 2019, within Biotechnology & Drugs Industry Leverage RatioJun 30 2019 MRQ Total LiabilitiesJun 30 2019 MRQ Equity
Wize Pharma, Inc.  4.52 $ 2.102  Millions$ 0.465  Millions
Amgen Inc.  4.50 $ 48,579.000  Millions$ 10,794.000  Millions
Alder Biopharmaceuticals Inc  3.19 $ 352.262  Millions$ 110.305  Millions
Apollo Endosurgery, Inc.  3.14 $ 56.649  Millions$ 18.037  Millions
Immunomedics, Inc.  3.11 $ 356.571  Millions$ 114.560  Millions
Cytomx Therapeutics, Inc.  2.99 $ 303.783  Millions$ 101.501  Millions
Sienna Biopharmaceuticals, Inc.  2.99 $ 80.642  Millions$ 26.983  Millions
Azurrx Biopharma, Inc.  2.73 $ 8.058  Millions$ 2.948  Millions
Orgenesis Inc.  2.63 $ 44.127  Millions$ 16.754  Millions
Cure Pharmaceutical Holding Corp.  2.50 $ 25.254  Millions$ 10.093  Millions
Axovant Gene Therapies Ltd.  2.46 $ 72.093  Millions$ 29.352  Millions
Cerecor Inc.  2.29 $ 40.587  Millions$ 17.696  Millions
Capricor Therapeutics, Inc.  2.07 $ 4.897  Millions$ 2.364  Millions
Adma Biologics, Inc.  2.05 $ 96.225  Millions$ 46.906  Millions
Arcturus Therapeutics Holdings Inc.  2.04 $ 44.046  Millions$ 21.618  Millions
Navidea Biopharmaceuticals, Inc.  2.00 $ 5.867  Millions$ 2.932  Millions
Chromadex Corp.  1.94 $ 29.397  Millions$ 15.145  Millions
Iterum Therapeutics Plc  1.90 $ 46.717  Millions$ 24.576  Millions
Intelgenx Technologies Corp.  1.89 $ 10.258  Millions$ 5.418  Millions
United Cannabis Corp  1.85 $ 9.565  Millions$ 5.166  Millions
Gt Biopharma, Inc.  1.85 $ 16.593  Millions$ 8.976  Millions
Nanostring Technologies Inc  1.67 $ 143.395  Millions$ 85.988  Millions
Gilead Sciences, Inc.  1.63 $ 37,009.000  Millions$ 22,751.000  Millions
Allergan Plc  1.56 $ 93,177.100  Millions$ 59,696.100  Millions
Soligenix, Inc.  1.49 $ 5.420  Millions$ 3.636  Millions
Aptevo Therapeutics Inc.  1.49 $ 39.034  Millions$ 26.199  Millions
Soleno Therapeutics Inc  1.47 $ 20.291  Millions$ 13.843  Millions
Wave Life Sciences Ltd.  1.41 $ 225.323  Millions$ 160.224  Millions
Emergent Biosolutions Inc.  1.35 $ 1,332.400  Millions$ 988.900  Millions
Infinity Pharmaceuticals, Inc.  1.31 $ 38.870  Millions$ 29.568  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FCUV's Profile

Stock Price

FCUV's Financials

Business Description

Fundamentals

Charts & Quotes

FCUV's News

Suppliers

FCUV's Competitors

Customers & Markets

Economic Indicators

FCUV's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071